FibroBiologics, Inc. Common Stock

General ticker "FBLG" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $16.9M (TTM average)

FibroBiologics, Inc. Common Stock does not follow the US Stock Market performance with the rate: -38.0%.

Estimated limits based on current volatility of 5.2%: low 0.86$, high 0.95$

Factors to consider:

  • Total employees count: 15 (+15.4%) as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Going concern doubt, Operational and conduct risks, Need for additional capital, FDA approval delays, Volatile stock price
  • Current price 93.4% below estimated low
  • Earnings for 15 months up through Q1 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [18.07$, 60.57$]
  • 2025-12-31 to 2026-12-31 estimated range: [13.07$, 42.39$]

Similar symbols

Short-term FBLG quotes

Long-term FBLG plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $4.47MM $8.89MM $13.74MM
Operating Income $-4.47MM $-8.89MM $-13.74MM
Non-Operating Income $-0.65MM $-7.60MM $2.58MM
Interest Expense $0.65MM $0.15MM $0.02MM
R&D Expense $1.15MM $2.37MM $4.50MM
Income(Loss) $-5.12MM $-16.48MM $-11.16MM
Net Income(Loss)* $-5.12MM $-16.48MM $-11.16MM
Stockholders Equity $-4.00MM $1.25MM $2.73MM
Assets $4.82MM $11.82MM $16.45MM
Operating Cash Flow $-4.07MM $-6.40MM $-11.90MM
Capital expenditure $0.00MM $0.49MM $0.18MM
Investing Cash Flow $0.00MM $-0.49MM $-0.18MM
Financing Cash Flow $5.92MM $13.79MM $16.91MM
Earnings Per Share** $-3.15 $-10.15 $-6.79

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.